Graf Akcie ENTA (Enanta Pharmaceuticals Inc). Diskuze k akciím ENTA. Aktuální informace ENTA.

Základní informace o společnosti Enanta Pharmaceuticals Inc (Akcie ENTA)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 1.4B
Hodnota podniku (EV) 882.89M
Tržby 97.13M
EBITDA -92.19
Zisk -83.74
Růst v tržbách Q/Q 15.93 %
Růst v tržbách Y/Y -35.31 %
P/E (Cena vůči ziskům) N/A
Forward P/E 3.00
EV/Sales 9.09
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 14.45
P/FCF N/A
Price/Book 3.08
Účetní hodnota na akcii 23.13
Hotovost na akcii 19.66
FCF vůči ceně -4.67 %
Počet zaměstnanců 141
Tržba na zaměstnance 688.865k
Profit margin -29.53 %
Operating margin -98.45 %
Gross margin 100.00 %
EBIT margin -95.56 %
EBITDA margin -94.92 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 67.61 %
EPS - Očekávaný růst příští rok -8.22 %
Return on assets -17.77 %
Return on equity -19.02 %
ROIC -7.18 %
ROCE -22.00 %
Dluhy/Equity 0.07
Čistý dluh/EBITDA 14.93
Current ratio 11.22
Quick Ratio 11.22
Volatilita 3.38
Beta 0.66
RSI 76.39
Cílová cena analytiků 68
Známka akcie (dle analytiků) 2.38
Insider ownership N/A %
Institutional ownership N/A %
Počet akcií 20.215M
Procento shortovaných akcií 11.98 %
Short ratio 18.32 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2013
Země United States

Finanční výsledky akcie ENTA

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$122.473$205.197$206.625$102.814$88.268$160.88
Cost Of Goods Sold------
Gross Profit$122.473$205.197$206.625$102.814$88.268$160.88
Research And Development Expenses$136.756$142.213$94.856$57.451$40.461$23.189
SG&A Expenses$27.356$26.246$23.441$20.749$16.966$13.543
Other Operating Income Or Expenses------
Operating Expenses$164.112$168.459$118.297$78.2$57.427$36.732
Operating Income$-41.639$36.738$88.328$24.614$30.841$124.148
Total Non-Operating Income/Expense$6.62$8.819$4.793$2.333$1.719$1.307
Pre-Tax Income$-35.019$45.557$93.121$26.947$32.56$125.455
Income Taxes$1.149$-0.826$21.165$9.237$10.894$46.463
Income After Taxes$-36.168$46.383$71.956$17.71$21.666$78.992
Other Income------
Income From Continuous Operations$-36.168$46.383$71.956$17.71$21.666$78.992
Income From Discontinued Operations------
Net Income$-36.168$46.383$71.956$17.71$21.666$78.992
EBITDA$-37.691$35.66$90.011$27.453$34.013$127.031
EBIT$-41.639$36.738$88.328$24.614$30.841$124.148
Basic Shares Outstanding202019191919
Shares Outstanding202121191919
Basic EPS$-1.81$2.37$3.74$0.93$1.14$4.23
EPS - Earnings Per Share$-1.81$2.21$3.48$0.91$1.13$4.09
# 2020 2019 2018 2017 2016 2015
Current Ratio18.083317.773823.737211.334429.427825.4536
Long-term Debt / Capital------
Debt/Equity Ratio------
Gross Margin100100100100100100
Operating Margin-33.998517.903842.74823.940334.940277.1681
EBIT Margin-33.998517.903842.74823.940334.940277.1681
EBITDA Margin-30.77517.378443.562526.701638.533878.9601
Pre-Tax Profit Margin-28.593222.201645.067626.209536.887777.9805
Net Profit Margin-29.531422.604134.824417.225324.545749.1
Asset Turnover0.25190.41890.49880.31480.31380.6539
Inventory Turnover Ratio------
Receiveable Turnover5.21343.99893.07459.68666.873910.2328
Days Sales In Receivables70.01291.2745118.716637.680853.099335.6696
ROE - Return On Equity-7.938910.028918.27785.87058.026333.4489
Return On Tangible Equity-7.938910.028918.27785.87058.026333.4489
ROA - Return On Assets-7.449.469217.37125.42197.702732.1089
ROI - Return On Investment-7.938910.028918.27785.87058.026333.4489
Book Value Per Share22.691623.473220.29815.77814.180312.6173
Operating Cash Flow Per Share-3.05051.991-1.29810.8504-2.1112.9219
Free Cash Flow Per Share-2.86471.877-1.31330.9677-2.23642.8545